Global and Region Barbiturate Drugs Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.

    Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user’s brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.Barbiturates become dangerous when combined with other depressants such as alcohol. There is a high risk of dependency from regular use of barbiturate drugs. This can be a physical dependency, psychological dependency, or both.

    The report details the trend, potential and market size of Barbiturate Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Barbiturate Drugsmarket, defines the market attractiveness level of Barbiturate Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Barbiturate Drugs industry, describes the types of Barbiturate Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Barbiturate Drugs market and the development prospects and opportunities of Barbiturate Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Barbiturate Drugs market in Chapter 13.

    By Player:

    • Sumitomo Dainippon Pharma

    • Oak Pharmaceuticals

    • Teva Pharmaceutical

    • Meda pharmaceuticals

    • Pfizer

    • Mylan

    • Merck

    • Valeant Pharmaceuticals

    • Sanofi

    • Eli Lilly

    By Type:

    • Ultra-Short Acting Barbiturate

    • Short-Acting Barbiturate

    • Long-Acting Barbiturate

    • Combination Drugs

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Barbiturate Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Barbiturate Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Barbiturate Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Barbiturate Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Barbiturate Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Barbiturate Drugs Consumption (2017-2022)

    • 7.2 United States Barbiturate Drugs Consumption (2017-2022)

    • 7.3 Europe Barbiturate Drugs Consumption (2017-2022)

    • 7.4 China Barbiturate Drugs Consumption (2017-2022)

    • 7.5 Japan Barbiturate Drugs Consumption (2017-2022)

    • 7.6 India Barbiturate Drugs Consumption (2017-2022)

    • 7.7 South Korea Barbiturate Drugs Consumption (2017-2022)

    8 Region and Country-wise Barbiturate Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Barbiturate Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Barbiturate Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Barbiturate Drugs Consumption Forecast (2022-2028)

    • 8.4 China Barbiturate Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Barbiturate Drugs Consumption Forecast (2022-2028)

    • 8.6 India Barbiturate Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Barbiturate Drugs Consumption Forecast (2022-2028)

    9 Global Barbiturate Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Barbiturate Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Ultra-Short Acting Barbiturate Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Short-Acting Barbiturate Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Long-Acting Barbiturate Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Combination Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Barbiturate Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Barbiturate Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Barbiturate Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Ultra-Short Acting Barbiturate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Short-Acting Barbiturate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Long-Acting Barbiturate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Combination Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Barbiturate Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Barbiturate Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Barbiturate Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Barbiturate Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Barbiturate Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Barbiturate Drugs Market Competitive Analysis

    • 14.1 Sumitomo Dainippon Pharma

      • 14.1.1 Sumitomo Dainippon Pharma Company Details

      • 14.1.2 Sumitomo Dainippon Pharma Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sumitomo Dainippon Pharma Barbiturate Drugs Product and Service

    • 14.2 Oak Pharmaceuticals

      • 14.2.1 Oak Pharmaceuticals Company Details

      • 14.2.2 Oak Pharmaceuticals Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Oak Pharmaceuticals Barbiturate Drugs Product and Service

    • 14.3 Teva Pharmaceutical

      • 14.3.1 Teva Pharmaceutical Company Details

      • 14.3.2 Teva Pharmaceutical Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Teva Pharmaceutical Barbiturate Drugs Product and Service

    • 14.4 Meda pharmaceuticals

      • 14.4.1 Meda pharmaceuticals Company Details

      • 14.4.2 Meda pharmaceuticals Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Meda pharmaceuticals Barbiturate Drugs Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Barbiturate Drugs Product and Service

    • 14.6 Mylan

      • 14.6.1 Mylan Company Details

      • 14.6.2 Mylan Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mylan Barbiturate Drugs Product and Service

    • 14.7 Merck

      • 14.7.1 Merck Company Details

      • 14.7.2 Merck Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck Barbiturate Drugs Product and Service

    • 14.8 Valeant Pharmaceuticals

      • 14.8.1 Valeant Pharmaceuticals Company Details

      • 14.8.2 Valeant Pharmaceuticals Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Valeant Pharmaceuticals Barbiturate Drugs Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Barbiturate Drugs Product and Service

    • 14.10 Eli Lilly

      • 14.10.1 Eli Lilly Company Details

      • 14.10.2 Eli Lilly Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Eli Lilly Barbiturate Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Barbiturate Drugs

    • Figure Barbiturate Drugs Picture

    • Table Global Barbiturate Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Barbiturate Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Barbiturate Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Barbiturate Drugs Consumption by Country (2017-2022)

    • Figure United States Barbiturate Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Barbiturate Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Barbiturate Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Barbiturate Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Barbiturate Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Barbiturate Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Barbiturate Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Barbiturate Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Barbiturate Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Barbiturate Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Barbiturate Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Barbiturate Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Barbiturate Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ultra-Short Acting Barbiturate Consumption and Growth Rate (2017-2022)

    • Figure Global Short-Acting Barbiturate Consumption and Growth Rate (2017-2022)

    • Figure Global Long-Acting Barbiturate Consumption and Growth Rate (2017-2022)

    • Figure Global Combination Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Ultra-Short Acting Barbiturate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Short-Acting Barbiturate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Long-Acting Barbiturate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Barbiturate Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Barbiturate Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Sumitomo Dainippon Pharma (Foundation Year, Company Profile and etc.)

    • Table Sumitomo Dainippon Pharma Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sumitomo Dainippon Pharma Barbiturate Drugs Product and Service

    • Table Oak Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Oak Pharmaceuticals Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oak Pharmaceuticals Barbiturate Drugs Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Barbiturate Drugs Product and Service

    • Table Meda pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Meda pharmaceuticals Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meda pharmaceuticals Barbiturate Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Barbiturate Drugs Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Barbiturate Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Barbiturate Drugs Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Barbiturate Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Barbiturate Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Barbiturate Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Barbiturate Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.